However, sorafenib blocks glutathione synthesis to inhibit glutathione peroxidase 4 (GPX4), which can clear lipid peroxide as a diverse route from ferritinphagy to boost ferroptosis in tumor cells. This evidence concerns the gene GPX4 and neoplasm.